amgen glp-1 obesity drug market potential Agonists Report 2025-2033, By Product, Molecule, and Geo amgen glp-1 obesity drug market
Description
Semaglutide at 2.4mg produced approximately 17% weight loss over 68 weeks
For these reasons, GLP-1 agonists are now being prescribed to aid weight loss
95% CI 5.15 to -1.99
Very low-calorie diets should only be followed under medical supervision
Further clinical trials are still needed
The product can be stored 3 years at 2 8 C or 4 weeks at room temperature below 25 C [23, 36]
